Amdocs director Amos Genish buys 3,565 shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Amdocs Ltd. (DOX) director Amos Genish reported a direct purchase of 3,565 ordinary shares at $42 per share on November 9, 2026, plus a separate direct award acquisition of 6,058 ordinary shares that day. The purchase was not reported under a Rule 10b5-1 plan.
Insider Trade Summary
Net Buyer: 3,565 shares
Net Buy
2 txns
Insider
Genish Amos
Role
Director
Bought
3,565 shs ($150K)
Increase in Position
31.4%
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Ordinary Shares | 3,565 | $42.00 | $150K |
| Grant/Award | Ordinary Shares | 6,058 | $0.00 | $0.00 |
Holdings After Transaction:
Ordinary Shares — 20,976 shares (Direct)
Holdings Before and After:
Ordinary Shares, 11,353 to 20,976 shares (Direct)
Other Insiders: 4 other insiders reported open-market purchases of this stock in the 30 days up to this filing.
Key Figures
Shares purchased: 3,565 shares
Purchase price: $42 per share
Award shares acquired: 6,058 shares
3 metrics
Shares purchased
3,565 shares
Direct purchase by Amos Genish on November 9, 2026
Purchase price
$42 per share
Amos Genish's purchase on November 9, 2026
Award shares acquired
6,058 shares
Direct grant or award acquisition by Amos Genish on November 9, 2026
Key Terms
Rule 10b5-1 plan
1 terms
Rule 10b5-1 plan regulatory
"the purchase was not reported under a Rule 10b5-1 plan"
A Rule 10b5-1 plan is a prearranged, written schedule that lets corporate insiders buy or sell company stock at set times or amounts, even if they later learn material nonpublic information. Think of it like setting an automatic thermostat for trades: it creates a clear record that trades were planned in advance, reducing the risk of insider-trading accusations and helping investors trust that insider transactions are routine rather than based on secret information.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.